肺部疾病的药物(PPT课件讲稿)Drugs used in pulmonary diseases

Drugs used in pulmonary diseases Antiasthmatic drugs Antitussives Expectorants Yang yun×a(杨云霞)
Drugs used in pulmonary diseases Antiasthmatic drugs Antitussives Expectorants Yang yun-xia (杨云霞)

Drugs used in pulmonary diseases Coughing Wheezing Sputum(phlegm) nflammation
Drugs used in pulmonary diseases Coughing Wheezing Sputum (phlegm) Inflammation

Drugs used in pulmonary diseases Cougbigging Wheezing Sputum(phlegm nflammation
Drugs used in pulmonary diseases Coughing Wheezing Sputum (phlegm) Inflammation Coughing

Pulmonary Pharmacology: Asthma General disease characteristics increased tracheobronchial responsiveness to many stimuli physiological air passage narrowing paroxysmal dyspnea, coughing, wheezing, chest tightness
Pulmonary Pharmacology: Asthma General disease characteristics: increased tracheobronchial responsiveness to many stimuli ↓ physiological air passage narrowing ↓ paroxysmal dyspnea, coughing, wheezing, chest tightness

Prevalence Very common disorder: 4-5%affected Typically presents in early life 50%of cases developed before age 10 33% before age 40
Prevalence: Very common disorder: 4-5% affected Typically presents in early life: 50% of cases developed before age 10; 33% before age 40

Etiology two broad types a① Allergic asthma:(gE) Histamine Ag-Ab- mast cell surface Trapase mediators release Leukotrienes Prostaglandins → muscle contraction pA vascular leakage mucus hyper secretion
Etiology----- two broad types ①Allergic asthma: (IgE) • Ag-Ab → mast cell surface • → mediators release • → muscle contraction • vascular leakage • mucus hyper secretion • Histamine Trapase Leukotrienes Prostaglandins PAF

Immunopathogenesis of asthma. Exposure to allergen cause synthesis of lgE, which binds to mast cell in airway mucosa On reexposure to allergen, Ag-Ab interaction on mast cell surface triggers release of mediators of anaphylaxis: Histamine, trypase, Prostaglandin D2, leukotriene C4, and platelet-activating factor. These agent provoke contraction of airway smooth muscle, causing immediate fall in FEV1 Reexposure to allergen also causes synthesis and release of cytokines: interleukins 4&5, granulocyte macrophage colony stimulatory factors, tumor necrosis factor and tissue growth factor from Tcells and mast cells. these cytokines attract and activate eosinophil and neutrophils, whose products include eosinophil cationic protein, major basic protein, proteases, and platelet activating factors. These mediators causes edema, mucus hypersecretion, smoothmuscle contraction, and increases in bronchi reactivity associated with late asthmatic response indicated by fall in FEv1 2-8 hrs after exposure Smooth muscle Blood vesse‘ Airway wall : Cell HistaminePGD ECPhis'sarte Proteases I PAF GM-CSF MBP解的PA TNF e的 TGF IgE Mast ce Tlymphocyte ALLERGEN
Immunopathogenesis of asthma. Exposure to allergen cause synthesis of IgE, which binds to mast cell in airway mucosa. On reexposure to allergen, Ag-Ab interaction on mast cell surface triggers release of mediators of anaphylaxis: Histamine,trypase, Prostaglandin D2, leukotriene C4, and platelet-activating factor. These agent provoke contraction of airway smooth muscle, causing immediate fall in FEV1. Reexposure to allergen also causes synthesis and release of cytokines: interleukins 4 & 5, granulocyte - macrophage colony stimulatory factors, tumor necrosis factor and tissue growth factor from Tcells and mast cells. These cytokines attract and activate eosinophil and neutrophils, whose products include eosinophil cationic protein, major basic protein, proteases, and platelet activating factors. These mediators causes edema, mucus hypersecretion, smoothmuscle contraction, and increases in bronchial reactivity associated with late asthmatic response indicated by fall in FEV1 2 -8 hrs after exposure

Histamine Bronchoconstriction Prostaglandin D2 Vascular congestion Edema Platelet activating Vascular leakage factor PAF tryptase Leukotrienes
Histamine Bronchoconstriction Vascular congestion Edema Vascular leakage Prostaglandin D2 Platelet activating factor PAF trypase Leukotrienes

Etiology ② idiosyncratic asthma normal serum IgE Nonantigenic stimul ● Stimulation- induced o exercises. inhaled irritants ect
②Idiosyncratic asthma: normal serum IgE Nonantigenic stimuli ⚫ Stimulation-induced ⚫ exercises, inhaled irritants ect Etiology

CNS Vagal afferent Vagal efferent ssue response cel (mast cell or eosinophil) Sensory receptor 7g9 Mediators from Inhaled irritant response cell Mucosa Preganglionic fiber Lumen Transmitter(ACh) Postganglionic neuron Sm。 oth muscle cells
按次数下载不扣除下载券;
注册用户24小时内重复下载只扣除一次;
顺序:VIP每日次数-->可用次数-->下载券;
- 西安培华医学院:《药物分析》课程教学资源(PPT实验课件讲稿)葡萄糖的分析、糊精的分析、阿司匹林片的分析、加味逍遥丸的分析、三黄片的质量分析、维生素B1片的分析、药房制剂的快速检验.ppt
- 中国医科大学:《药物分析》课程教学资源(PPT课件讲稿)第十章 甾体激素类药物的分析.ppt
- 《药物分析》课程教学资源(PPT课件讲稿)第五章 巴比妥类药物的分析(Analysis of Barbitals Drugs).ppt
- 长春工业大学:《药物合成反应》课程教学资源(PPT课件讲稿)第三章 酰化反应(石富强).ppt
- 治疗心血管疾病的药物(PPT课件讲稿)抗休克药.ppt
- 湖北职业技术学院:《护理药理》课程教学资源(PPT课件讲稿)镇静催眠药及药疗护理.pps
- 《药理学》课程教学资源(PPT课件讲稿)化疗药物 Chemotherapeutic Medicine.ppt
- 《发酵制药》课程教学资源(PPT课件讲稿)放线菌发酵制药(四环素发酵).ppt
- 河北医科大学药学院:《药物分析》课程教学资源(教学大纲)药物分析考试大纲 Pharmaceutical Analysis.doc
- 《中国药典》2005年版阿司匹林片剂含量测定方法的商榷.pdf
- 中国科学技术大学:心血管药物(PPT课件讲稿)Cardiovascular drugs.ppt
- 山东大学医学院:治疗帕金森病的药物 Motor systems II:The basal ganglia and Drugs used for the treatment of Parkinson’s disease.ppt
- 西安交通大学:《制药工程学》课程教学资源(PPT课件讲稿)第五章 能量衡算 Energy Balance(主讲:孟歌).ppt
- 北京大学医院内科PPT讲稿:合理用药知识讲座(李卫菊).pptx
- 西安交通大学:《化学制药工艺学》课程教学资源(PPT课件讲稿)第四章 物料衡算 Material Balance(主讲:孟歌).ppt
- 药物(代谢)动力学(PPT课件讲稿)pharmacokinetics.ppt
- 西安交通大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)第五章 心血管系统药物 Cardiovascular Drugs.ppt
- 《药理学》课程教学资源(PPT课件讲稿)葫芦科 Cucurbitaceae、桔梗科 Cltmpanulaceae.ppt
- 《药理学》课程教学资源(PPT课件)第四十一章 抗结核病药.ppt
- 《药理学》课程教学资源(PPT课件讲稿)第六章 胆碱受体激动药 cholinoceptor agonists.ppt
- 山西医科大学:《生药学 Pharmacognosy》课程教学资源(PPT课件讲稿)根及根茎类生药(主讲:李建宽).ppt
- 《化学制药工艺学》课程教学资源(PPT课件讲稿)第五章 中试放大与生产工艺规程 Scale-ups and manufacture technological rules.ppt
- 山西医科大学药学院:《生药学 Pharmacognos》课程教学资源(PPT课件讲稿)第二篇 各论(白云娥)第八章 藻、菌类生药 Algae- Fungi Drugs.ppt
- 复旦大学:《药物分析 Pharmaceutical Analysis》课程教学资源(PPT课件讲稿)第十六章 抗生素类药物的分析.ppt
- 长沙医学院:《药剂学》课程教学资源(PPT课件讲稿)第二章 液体制剂(主讲:黄明秋).ppt
- 长沙医学院:《药物分析》课程教学资源(PPT课件讲稿)第四章 药物定量分析样品与分析方法验证.ppt
- 中枢神经系统药理学(PPT课件讲稿)中枢神经系统药理概论、镇静催眠药、抗癫痫药及抗惊厥药、抗帕金森病药、抗精神失常药、镇痛药.ppt
- 《药理学》课程教学资源(PPT课件讲稿)β-内酰胺类抗生素.ppt
- 西安交通大学:《制药工程学》课程教学资源(PPT课件讲稿)第三章 工艺流程设计 Design of Engineering & Process Flow.ppt
- 西安交通大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)第九章 抗生素 Antibiotics(孟歌).ppt
- 抗精神失常药物(PPT课件讲稿)Antipsychotics Psychotherapeutic drugs.ppt
- 西安交通大学:《药物分析》课程教学资源(PPT课件讲稿)第十章 甾体激素类药物的分析 The Analysis of Steroid Hormone Drugs.ppt
- 吉首大学:《药理学》课程教学大纲 Pharmacology B.pdf
- 重庆医科大学:获取药学信息的途径与方法(PPT培训讲座)新药研究的信息调研.ppt
- 长沙医学院:《药物分析》课程教学资源(PPT课件)第二章 药品的鉴别试验 Identification test of drug.ppt
- 《药物毒理学》课程教学资源(PPT课件讲稿)第十六章 人类药物依赖性及戒毒药.ppt
- 山东大学:新药开发和审批流程(PPT课件讲稿)New Drug Development and Approval Process.ppt
- 《仪器分析新进展》课程教学资源_教学大纲 Development of Instrumental.doc
- 黔南民族医学高等专科学校:《药物化学》课程教学资源(PPT课件讲稿)绪论.ppt
- 《毒理学》课程教学资源(PPT课件)第十九章 局部用药的毒性研究.ppt